IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
6
Neutral
6
Bullish
2
Bearish
31
Neutral
6
Bullish
9
Bearish
25
Neutral
0
Bullish
7
Bearish
25
Neutral
0
Bullish
7
Bearish
25
Neutral
0
Bullish
7
Bearish
25
Neutral
0
Bullish
7
Investor Presentation
Q3 FY26
Pentokey Organy (India) Ltd (PNTKYOR) is currently trading at 28.89 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Pentokey Organy (India) Limited is a small Indian chemical trading and manufacturing company that trades and supplies pharmaceutical solvents and intermediates including Acetic Acid, Ethyl Acetate and Acetaldehyde, and historically operates an intermediate production capability with a stated manufacturing capacity of 24,000 TPA for intermediates. Q1 FY2027 results show Total Income of Rs. 8.34 lakh and Profit after tax of Rs. 21.73 lakh, while Total Comprehensive Income was boosted to Rs. 39.19 lakh by a sizeable Other Comprehensive Income item of Rs. 17.46 lakh; these quarter numbers contrast materially with prior-period Total Income of Rs. 510.20 lakh. Strategically, the company remains a trader/manufacturer focused on eco-preferred solvents such as Ethyl Acetate, and in June 2025 amended its objects to add trading in fertilizers and pesticides, indicating management is diversifying its trading portfolio beyond pharmaceutical solvents into adjacent agrochemical markets. Operationally, Pentokey has historically increased intermediate production capacity from 18,000 TPA to 24,000 TPA and sources ethanol from regional distilleries when competitive, reflecting a hybrid model of manufacturing plus market purchases that creates margin exposure to commodity and feedstock pricing volatility. Corporate governance notes: the Board approved the unaudited Q1 results on 13 August 2026 and the statutory auditors issued an unmodified limited review opinion, providing formal assurance on the interim financial reporting for investors and regulators.
Over the past 52 weeks, Pentokey Organy (India) Ltd has traded between a low of ₹25.00 and a high of ₹57.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Pentokey Organy (India) Ltd has a market capitalization of approximately 18.53. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Pentokey Organy (India) Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -185.30 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 18.53 Cr, Pentokey Organy (India) Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Pentokey Organy (India) Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Pentokey Organy (India) Ltd is -185.30. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Pentokey Organy (India) Limited is a small Indian chemical trading and manufacturing company that trades and supplies pharmaceutical solvents and intermediates including Acetic Acid, Ethyl Acetate and Acetaldehyde, and historically operates an intermediate production capability with a stated manufacturing capacity of 24,000 TPA for intermediates.
Q1 FY2027 results show Total Income of Rs. 8.34 lakh and Profit after tax of Rs. 21.73 lakh, while Total Comprehensive Income was boosted to Rs. 39.19 lakh by a sizeable Other Comprehensive Income item of Rs. 17.46 lakh; these quarter numbers contrast materially with prior-period Total Income of Rs. 510.20 lakh.
Strategically, the company remains a trader/manufacturer focused on eco-preferred solvents such as Ethyl Acetate, and in June 2025 amended its objects to add trading in fertilizers and pesticides, indicating management is diversifying its trading portfolio beyond pharmaceutical solvents into adjacent agrochemical markets.
Operationally, Pentokey has historically increased intermediate production capacity from 18,000 TPA to 24,000 TPA and sources ethanol from regional distilleries when competitive, reflecting a hybrid model of manufacturing plus market purchases that creates margin exposure to commodity and feedstock pricing volatility.
Corporate governance notes: the Board approved the unaudited Q1 results on 13 August 2026 and the statutory auditors issued an unmodified limited review opinion, providing formal assurance on the interim financial reporting for investors and regulators.
Chemicals & Petrochemicals
Commodity Chemicals
19 Cr
Low Risk
-185.3
34.6
-1.1
1.9
57.00
25.00
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
46.01 | 21 Cr | 50.38 | 3.22 | 0.00 | 26.76 | 18.25 | 2.46 | ||
48.71 | 21 Cr | 6.01 | 0.56 | 0.00 | 9.33 | 12.53 | 8.49 | ||
6.37 | 19 Cr | -239.75 | 1.84 | 0.00 | 5.20 | 5.38 | 2.34 | ||
28.89 | 19 Cr | -185.30 | 1.91 | 0.00 | 2.28 | 2.28 | 2.38 | ||
31.35 | 18 Cr | -108.65 | 38.73 | 0.00 | -41.50 | -2.16 | -2.02 | ||
18.80 | 17 Cr | 20.96 | 1.12 | 0.00 | 5.04 | 11.82 | 2.11 | ||
9.00 | 16 Cr | -32.62 | 0.00 | 0.00 | 3.02 | 9.48 | -14.11 | ||
| Median: 7 Co. | — | 28.89 | 19 Cr | -32.62 | 1.84 | 0.00 | 5.04 | 9.48 | 2.34 |
